Stay updated on Niraparib & Pembrolizumab in TNBC & Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Niraparib & Pembrolizumab in TNBC & Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Niraparib & Pembrolizumab in TNBC & Ovarian Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision tag on the study page was updated from v3.6.4 to v3.6.5, indicating a minor publication/version update. This change does not modify study details, eligibility criteria, outcomes, or other user-facing content.
    Difference
    0.0%
    Check dated 2026-08-10T14:51:30.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.6.4 is now shown, replacing the previous Revision: v3.6.3, which indicates a minor internal update to the page template or documentation.
    Difference
    0.0%
    Check dated 2026-07-27T06:24:29.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.3, replacing Revision: v3.6.2, updating the study record's version metadata.
    Difference
    0.0%
    Check dated 2026-07-05T13:47:45.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The page revision tag changed from v3.6.0 to v3.6.2, indicating a new page build. This likely represents maintenance or a small fix to the study details page rather than a content update.
    Difference
    0.0%
    Check dated 2026-06-28T08:20:53.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    The study record page now includes new navigation/help sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study', and the heading for 'Intervention/Treatment' has replaced the old 'Intervention / Treatment' label with a new 'Revision: v3.6.0'. It also displays 'No longer looking for participants', indicating the study is not currently enrolling.
    Difference
    0.3%
    Check dated 2026-06-14T05:35:19.000Z thumbnail image
  9. Check
    84 days ago
    Change Detected
    Summary
    The revision label in the study documents area was updated from v3.5.4 to v3.5.5, indicating a newer version of the document.
    Difference
    0.0%
    Check dated 2026-06-07T01:50:30.000Z thumbnail image

Stay in the know with updates to Niraparib & Pembrolizumab in TNBC & Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Niraparib & Pembrolizumab in TNBC & Ovarian Cancer Clinical Trial page.